Ozone confirms that Rothschild is its sale advisor

Pharmaceutical company Ozone Laboratories posted a 40% first-half sales increase for its Ceclozone, Algozone, Entran and Paracetamol Ozone brands compared with the same period in 2007. The company’s overall sales amounted to 17.5 million euros in the first half, 28% higher than previous results. Ozone shareholders are businessmen Ludovic Robert, Michel Eid, Roger Akoury and Walid Abboud, who also hold the majority stake in the largest Romanian pharmaceutical group, A&D Pharma. Lately, information has emerged on the market that suggests they have hired Rothschild investment bank to assist them in Ozone’s sale process. “Rothschild is one of our advisors, offering us advisory services regarding strategic development alternatives over the coming period,” said Christopher Henwood, CEO of Ozone Laboratories.